Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,908
Closed -$233K 103
2023
Q1
$233K Sell
1,908
-4,336
-69% -$546K 0.06% 94
2022
Q4
$779K Sell
6,244
-586
-9% -$71.9K 0.2% 53
2022
Q3
$722K Sell
6,830
-223
-3% -$24.1K 0.18% 65
2022
Q2
$755K Sell
7,053
-285
-4% -$34.8K 0.18% 73
2022
Q1
$965K Buy
+7,338
New +$863K 0.21% 66
2021
Q4
Sell
-9,750
Closed -$893K 83
2021
Q3
$893K Buy
9,750
+947
+11% +$93.5K 0.21% 85
2021
Q2
$952K Sell
8,803
-155
-2% -$17.9K 0.23% 81
2021
Q1
$991K Sell
8,958
-1,444
-14% -$160K 0.25% 79
2020
Q4
$1.2M Sell
10,402
-4,483
-30% -$499K 0.34% 61
2020
Q3
$1.58M Sell
14,885
-2,207
-13% -$236K 0.52% 42
2020
Q2
$1.7M Buy
+17,092
New +$1.58M 0.6% 39

Other funds holding FMC

Human Investing's FMC Position: Q2 2023 in Review

Human Investing sold out of FMC (FMC) in Q2 2023, closing a stake of 1,908 shares — an estimated $233K sold.

Human Investing first reported a position in FMC in Q2 2020 and held it in 11 quarters. The position peaked at $1.7M in Q2 2020. 683 funds tracked by Wall St. Rank hold FMC as of Q2 2023.

  • Human Investing reported no remaining FMC position as of Q2 2023 after selling out during the quarter.
  • Human Investing sold 1,908 FMC shares in Q2 2023, an estimated $233K.
  • Human Investing first reported a position in FMC in Q2 2020 and held it in 11 quarters.
  • Human Investing's FMC position peaked at $1.7M in Q2 2020.
  • 683 funds tracked by Wall St. Rank held FMC as of Q2 2023.

Based on Human Investing's 13F filing for Q2 2023, filed 7 Aug 2023.